2019
DOI: 10.3390/ijms20082032
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular l-arginine Enhances Relaxations Induced by Opening of Calcium-Activated SKCa Channels in Porcine Retinal Arteriole

Abstract: We investigated whether the substrate for nitric oxide (NO) production, extracellular l-arginine, contributes to relaxations induced by activating small (SKCa) conductance Ca2+-activated potassium channels. In endothelial cells, acetylcholine increased 3H-l-arginine uptake, while blocking the SKCa and the intermediate (IKCa) conductance Ca2+-activated potassium channels reduced l-arginine uptake. A blocker of the y+ transporter system, l-lysine also blocked 3H-l-arginine uptake. Immunostaining showed co-locali… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…However, the combination of TRAM-34 with UCL1684, a blocker of SK Ca channels, decreased pirfenidone relaxation in mouse coronary arteries (Figure 3D). As these channels are involved in release of endothelium-derived NO (Stankevicius et al, 2011;Simonsen et al, 2019), these results suggest that pirfenidone modifies the release or the effect of NO in the smooth muscle layer. A blocker of voltage-gated K V 7 channels, XE991 (10 −5 M) blocked the pirfenidone relaxation (Figure 3E), and 10 −4 M pirfenidone relaxed the mouse coronary arteries with 14 ± 7% (p < 0.05, n 6) in the presence of XE991.…”
Section: Mechanisms Involved In Pirfenidone Relaxation In Mouse Coron...mentioning
confidence: 83%
“…However, the combination of TRAM-34 with UCL1684, a blocker of SK Ca channels, decreased pirfenidone relaxation in mouse coronary arteries (Figure 3D). As these channels are involved in release of endothelium-derived NO (Stankevicius et al, 2011;Simonsen et al, 2019), these results suggest that pirfenidone modifies the release or the effect of NO in the smooth muscle layer. A blocker of voltage-gated K V 7 channels, XE991 (10 −5 M) blocked the pirfenidone relaxation (Figure 3E), and 10 −4 M pirfenidone relaxed the mouse coronary arteries with 14 ± 7% (p < 0.05, n 6) in the presence of XE991.…”
Section: Mechanisms Involved In Pirfenidone Relaxation In Mouse Coron...mentioning
confidence: 83%